Transforming Research and Clinical Knowledge in Geriatric Traumatic Brain Injury (TRACK-GERI)
TRACK-GERI
5 other identifiers
observational
1,500
1 country
3
Brief Summary
The purpose of this study is to improve the diagnosis and prediction of recovery after traumatic brain injury (TBI) in adults age 65 years and older. The study will follow older adults who present to the emergency department after TBI, as well as matched control participants, and will measure clinical features, brain imaging, and blood-based biomarkers over 12 months to understand how recovery changes over time. Researchers will examine how pre-injury health, brain structure, and biological markers are related to disability and cognitive outcomes after TBI. Information from this study will be used to develop age-appropriate tools to better diagnose TBI and estimate long-term outcomes in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2019
CompletedFirst Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 22, 2025
December 1, 2025
7.3 years
December 16, 2025
December 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Functional Outcome at 6 Months Post-Injury as Assessed by the Glasgow Outcome Scale-Extended (GOSE)
Functional outcome after traumatic brain injury will be measured using the Glasgow Outcome Scale-Extended (GOSE). The score ranges from 1-8, with higher scores indicating better recovery. The primary outcome is GOSE assessed at 6 months post-injury.
6 months post-injury
Study Arms (8)
TRACK-GERI TBI Patients
TBI patients
TRACK-GERI Study Partners of TBI Patients
Study partners of TBI patients
TRACK-GERI Controls
Controls
TRQACK-GERI Study Partners of Control Patients
Study partners of control patients
TRACK-VA TBI Patients
VA TBI patients
TRACK-VA Study Partners of TBI Patients
Study partners of VA TBI patients
TRACK-VA Controls
VA controls
TRACK-VA Study Partners of Control Patients
Study partners of VA control patients
Eligibility Criteria
Participants are those with and without TBI, along with study partners.
You may not qualify if:
- Age 65 years and older, no upper age limit
- Reliable report or physical evidence of head trauma
- Injury occurred \<72 hours ago (within 14 days of injury for TRACK-VA TBI patients)
- Acute brain CT for clinical use
- Fluency in English/Chinese (UCSF only)
- Ability to obtain informed consent from subject or legally authorized representative
- Ability to be co-enrolled with a study partner who meets Study Partner enrollment criteria
- Significant polytrauma that would interfere with follow-up and outcome assessment
- Prisoners or patients in custody
- Patients on psychiatric hold (e.g. 5150, 5250)
- Low likelihood follow-up (participant or family is indicating a low interest, homelessness, out of state/country)
- Current participation in an interventional trial
- Penetrating TBI
- Spinal cord injury with ASIA score of C or worse
- Acute disabling neurological injury (e.g. acute stroke, cardiac arrest concurrent with head trauma presentation)
- +29 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Doris Duke Charitable Foundationcollaborator
- National Institute on Aging (NIA)collaborator
- United States Department of Defensecollaborator
- US Department of Veterans Affairscollaborator
- National Institute of Neurological Disorders and Stroke (NINDS)collaborator
Study Sites (3)
University of California, San Francisco
San Francisco, California, 94110, United States
San Francisco Veterans Affairs Medical Center
San Francisco, California, 94121, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Related Links
Biospecimen
Participants will undergo phlebotomy for whole blood collection.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geoffrey Manley, MD, PhD
University of California, San Francisco
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 22, 2025
Study Start
September 2, 2019
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Shared scientific data will be made accessible as soon as possible, and no later than the time of an associated publication, or the end of performance period, whichever comes first.
- Access Criteria
- FITBIR qualified investigators will be provided access.
Data will be made available through the Federal Interagency TBI Research (FITBIR) Database.